QNTM is trading 5.1% down at $3.73 as the stock gives back gains from a strong previous session amid ongoing volatility.

  • The move follows a 5.4% rally in the prior session, suggesting today's price action is driven by stock-specific profit-taking rather than a broader market catalyst.
  • No new company-specific news was reported for June 26, 2026, with investor attention still centered on the company’s patented MS therapy program.
  • While tech and risk assets have been trading unevenly, the current decline appears to be noise following a recent run of volatile trading.